Pharmacist Continuing Education

Free Pharmacist Continuing Education – ACPE Topic 01: Disease State Management / Drug Therapy

Browse free pharmacist continuing education activities categorized under ACPE Topic 01: Disease State Management and Drug Therapy. Use the filters below to search by provider, credit hours, or course information.

Available ACPE Topic 01 Continuing Education Activities

Select “View Free CE” to visit the provider’s registration page. A free provider account may be required, but the CE activities listed do not require a paid membership.

TITLEHOURSUANPROVIDEREXPIRATIONREGISTRATION
Improving Prostate Cancer Outcomes with Androgen Receptor Pathway Inhibition: Pharmacist Viewpoints on Emerging Data and Evolving Best Practices0.750430-0000-25-099-H01-PPowerPakFree10/29/2026https://www.powerpak.com/course/preamble/135984View Free CE
Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum1.00JA0007144-0000-26-429-L01-PPrimeFree10/29/2026https://primeinc.org/virtual/optimizing-care-transitions-referral-decision-making-across-hnscc-continuumView Free CE
Transforming LDL-C Management: Advancing Treatment Beyond Statins to Reduce ASCVD Risk1.50JA0007144-0000-25-458-H01-PPrimeFree10/30/2026https://primeinc.org/online/transforming-ldl-c-management-advancing-treatment-beyond-statins-reduce-ascvdView Free CE
Advancing Care for Uncomplicated UTIs: Evidence, Equity, and Evolving Treatments1.50JA0007144-0000-25-457-H01-PPrimeFree10/30/2026https://primeinc.org/online/advancing-care-uncomplicated-utis-evidence-equity-evolving-treatmentsView Free CE
Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction1.000290-0000-25-349-H01-PPharmacy TimesFree10/30/2026https://www.pharmacytimes.org/courses/optimizing-lipid-management-in-statin-intolerant-populations-payer-strategies-for-evidence-based-access-and-risk-reduction-8x4xView Free CE
From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings1.000290-9999-25-356-H01-PPharmacy TimesFree11/02/2026https://www.pharmacytimes.org/courses/from-guidelines-to-action-implementing-pneumococcal-vaccine-acip-recommendations-in-long-term-care-settings-daz5View Free CE
Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care1.500290-0000-25-363-H01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/bridging-innovation-and-access-in-hr-positiveher2-negative-metastatic-breast-cancer-implications-for-managed-care-fr9zView Free CE
New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights1.500290-0000-25-366-H01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/new-horizons-in-attr-cm-therapeutic-advances-and-strategic-insights-713xView Free CE
Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care1.500290-0000-25-365-H01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/cardiorenal-protection-with-sglt2-inhibitors-perspectives-for-managed-care-30hyView Free CE
Directions in Oncology Pharmacy® 2026 Northeast1.000290-0000-26-272-L01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/directions-in-oncology-pharmacy-northeastView Free CE
Directions in Oncology Pharmacy® 2026 Northeast1.000290-0000-26-273-L01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/directions-in-oncology-pharmacy-northeastView Free CE
Directions in Oncology Pharmacy® 2026 Northeast1.000290-0000-26-274-L01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/directions-in-oncology-pharmacy-northeastView Free CE
Directions in Oncology Pharmacy® 2026 Northeast1.000290-0000-26-281-L01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/directions-in-oncology-pharmacy-northeastView Free CE
Directions in Oncology Pharmacy® 2026 Northeast1.000290-0000-26-282-L01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/directions-in-oncology-pharmacy-northeastView Free CE
Directions in Oncology Pharmacy® 2026 Northeast1.000290-0000-26-283-L01-PPharmacy TimesFree11/07/2026https://www.pharmacytimes.org/courses/directions-in-oncology-pharmacy-northeastView Free CE
Scalpel to Systemic: Navigating Referral Crossroads and MDT Decision-Making in HNSCC0.50JA0007144-0000-26-430-L01-PPrimeFree11/09/2026https://primeinc.org/virtual/scalpel-systemic-navigating-referral-crossroads-mdt-decision-making-hnsccView Free CE
Achieving Improved Ocular Surface Health in Dry Eye Disease: A Pharmacy-Focused Review at the Forefront of a New Treatment Era (PHARMACISTS)2.000430-0000-25-119-H01-PPowerPakFree11/10/2026https://www.powerpak.com/course/preamble/138888View Free CE
Real-Time Continuous Glucose Monitoring: Setting the Stage for a New Standard of Care in the Hospital1.50 JA4008258-0000-23-337-H01-PAssociation of Diabetes Care & Educational SpecialistsFree11/15/2026https://www.adces.org/store/online-education/detail/rt-cgm-setting-the-stage-for-a-new-standard-of-care-in-the-hospital-recordedView Free CE
The Next Move: Sequencing Systemic Therapy and Coordinating Care Across the HNSCC Continuum0.50JA0007144-0000-26-431-L01-PPrimeFree11/16/2026https://primeinc.org/virtual/next-move-sequencing-systemic-therapy-coordinating-care-across-hnscc-continuumView Free CE
Transforming Outcomes in Severe Asthma: Opportunities to Address Unmet Needs and Support Equitable Care Amid an Evolving Landscape1.00JA0007144-0000-25-499-H01-P PrimeFree11/20/2026https://primeinc.org/online/transforming-outcomes-severe-asthma-opportunities-address-unmet-needs-supportView Free CE
Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals1.000290-0000-25-381-H01-PPharmacy TimesFree11/21/2026https://www.pharmacytimes.org/courses/addressing-gaps-in-care-for-the-rapid-and-long-term-management-of-hyperkalemia-with-novel-oral-potassium-binding-agents-insights-for-managed-care-professionals-ibprView Free CE
Constipation Clash: An IBS-C Challenge1.50JA0007105-0000-25-417-H01-PMedscapeFree11/24/2026https://www.medscape.org/viewarticle/constipation-clash-ibs-c-challenge-2025a1000vgiView Free CE
Mycophenolate REMS in Practice: Counseling, Communication, and Risk Reduction1.250430-0000-25-095-H01-PPowerPakFree11/26/2026https://www.powerpak.com/course/preamble/127265View Free CE
Optimizing the 1L Management of Advanced Renal Cell Carcinoma: Focus on the Evolving Evidence and Best Practices for ICI-TKI Combinations1.500430-9999-26-040-H01-PPowerPakFree11/28/2026https://www.powerpak.com/course/preamble/208185View Free CE
Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: From Fast Facts to Patient-Centered Solutions1.50JA0007105-0000-25-415-H01-PMedscapeFree12/02/2026https://www.medscape.org/viewarticle/cardiac-myosin-inhibitors-hypertrophic-cardiomyopathy-fast-2025a1000x5iView Free CE
Continuing the Conversation: Optimizing Fibrosing ILD Outcomes: A Pharmacist-Led Approach to Evidence-Based Care1.000290-0000-26-290-L01-PPharmacy TimesFree12/03/2026https://www.pharmacytimes.org/courses/continuing-the-conversation-optimizing-fibrosing-ild-outcomes-a-pharmacist-led-approach-to-evidence-based-careView Free CE
Essential GLP-1 Receptor Agonist Updates for Pharmacists: Optimizing Care and Outcomes in Type 2 Diabetes (Archive)1.500430-0000-25-100-H01-PPowerPakFree12/04/2026https://www.powerpak.com/course/preamble/126994View Free CE
HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data1.000290-0000-25-393-H01-PPharmacy TimesFree12/05/2026https://www.pharmacytimes.org/courses/her2-positive-metastatic-breast-cancer-a-managed-care-perspective-on-emerging-therapies-and-clinical-data-n03nView Free CE
Mycophenolate REMS in Practice: Why, What, and When?0.750430-0000-25-097-H01-PPowerPakFree12/08/2026https://www.powerpak.com/course/preamble/151415View Free CE
Translating Evidence to Practice: Guideline-Directed LDL-C Lowering and Nonstatin Strategies to Achieve Treatment Goals1.00JA0007144-0000-25-533-H01-PPrimeFree12/10/2026https://primeinc.org/online/translating-evidence-practice-guideline-directed-ldl-c-lowering-nonstatinView Free CE
Expert Discussion on Optimized Use of GLP-1RAs in Type 2 Diabetes – Pearls for the Practicing Pharmacist0.750430-0000-25-102-H01-PPowerPakFree12/11/2026https://www.powerpak.com/course/preamble/142283View Free CE
Bispecific Antibodies in Action: Applying Evidence Across the DLBCL and FL Care Continuum2.00JA0007144-0000-26-424-L01-PPrimeFree12/11/2026https://primeinc.org/live/bispecific-antibodies-action-applying-evidence-across-dlbcl-fl-care-continuumView Free CE
Bridging the REMS Gaps: Pharmacist Strategies for Safer and More Effective Mycophenolate Use2.000430-0000-25-096-H01-PPowerPakFree12/15/2026https://www.powerpak.com/course/preamble/188593View Free CE
Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma: A Case Based Discussion1.25JA0007105-0000-25-452-H01-PMedscapeFree12/18/2026https://www.medscape.org/viewarticle/tailoring-bispecific-antibodies-individualize-r-r-follicular-2025a1000zipView Free CE
Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion1.25JA0007105-0000-25-453-H01-PMedscapeFree12/18/2026https://www.medscape.org/viewarticle/personalizing-relapsed-refractory-dlbcl-bispecific-antibody-2025a1000zirView Free CE
Advancing Equitable Prostate Cancer Care: Evidence-Based Strategies for Improving Outcomes in Rural and Underserved Communities – Lessons Learned1.00JA4008332-0000-25-100-H01-PFreeCMEFree12/19/2026https://www.freecme.com/products/advancing-equitable-prostate-cancer-care-evidence-based-strategies-for-improving-outcomes-in-rural-and-underserved-communities-lessons-learnedView Free CE
Update on Use of GLP-1 RAs in Type 2 Diabetes2.000430-0000-25-101-H01-PPowerPakFree12/19/2026https://www.powerpak.com/course/preamble/175172View Free CE
Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients1.000290-0000-25-420-H01-PPharmacy TimesFree12/19/2026https://www.pharmacytimes.org/courses/advancing-chronic-kidney-disease-detection-and-cardiovascular-risk-reduction-in-complex-patients-01fxView Free CE
Real-Time Insights Into the Diagnosis and Management of ATTR: From Genetic Insight to Therapeutic Innovation1.25JA0007105-0000-25-430-H01-PMedscapeFree12/23/2026https://www.medscape.org/viewarticle/real-time-insights-diagnosis-and-management-attr-genetic-2025a1000yeoView Free CE
Hat Trick for Hypertension: Strategies to Improve Outcomes With Single-Pill Combinations1.000290-0000-25-424-H01-PPharmacy TimesFree12/24/2026https://www.pharmacytimes.org/courses/hat-trick-for-hypertension-strategies-to-improve-outcomes-with-single-pill-combinations-lbz7View Free CE
Targeting the RAS/RAF/MAPK Pathway in Recurrent Low-Grade Serous Ovarian Cancer:A New Era in the Evolution of Precision Medicine (Archive)1.000430-0000-26-056-H01-PPowerPakFree12/25/2026https://www.powerpak.com/course/preamble/208295View Free CE
Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease, and Acute Intermittent Porphyria1.25JA0007105-0000-25-457-H01-PMedscapeFree12/29/2026https://www.medscape.org/viewarticle/rare-clinical-spotlight-exploring-castleman-disease-cold-2025a100104iView Free CE
The Evolving Sequencing of TKIs for HER2-Mutated, Non-Small Cell Lung Cancer: Essential Updates for Oncology, Managed Care, and Specialty Pharmacists2.000430-0000-25-137-H01-PPowerPakFree12/31/2026https://www.powerpak.com/course/preamble/207683View Free CE
The Evolving Sequencing of TKIs for HER2-Mutated, Non-Small Cell Lung Cancer: Essential Updates for Oncology, Managed Care, and Specialty Pharmacists (Recorded Podcast)0.500430-0000-25-142-H01-PPowerPakFree12/31/2026https://www.powerpak.com/course/preamble/207677View Free CE
Obesity Pharmacotherapy Continues to Gain Momentum: How Pharmacists Can Support and Monitor Patients on GLP-1 Weight-Loss Therapy0.750430-0000-25-136-H01-PPowerPakFree12/31/2026https://www.powerpak.com/course/preamble/192553View Free CE
Obesity Pharmacotherapy Continues to Gain Momentum: How Pharmacists Can Support and Monitor Patients on GLP-1 Weight-Loss Therapy2.000430-0000-25-135-H01-PPowerPakFree12/31/2026https://www.powerpak.com/course/preamble/207684View Free CE
Ironing Out the Gaps: How to Test, When to Treat, and How to Administer IV Iron in Patients with Heart Failure1.500430-0000-25-117-H01-PPowerPakFree12/31/2026https://www.powerpak.com/course/preamble/139287View Free CE
Patient-Centered Approaches to Indolent Systemic Mastocytosis: Advancing Care and Reducing Diagnostic Delays1.75JA0007105-0000-26-044-H01-PMedscapeFree01/05/2027https://www.medscape.org/viewarticle/patient-centered-approaches-indolent-systemic-mastocytosis-2025a100106vView Free CE
Obesity Pharmacotherapy Continues to Gain Momentum: How Pharmacists Can Support and Monitor Patients on GLP-1 Weight-Loss Therapy1.000430-0000-26-014-H01-PPowerPakFree01/21/2027https://www.powerpak.com/course/preamble/207697View Free CE
New Drug Approvals for 2025 (Pharmacist Credit)2.000290-0000-25-410-H01-PPharmacy TimesFree01/26/2027https://www.pharmacytimes.org/courses/new-drug-approvals-for-2025-pharmacist-creditView Free CE
Joint Efforts: Pharmacist Focus on Supporting Mobility and Independence Through Supplement Use2.000430-0000-26-011-H01-PPowerPakFree01/29/2027https://www.powerpak.com/course/preamble/207777View Free CE
Panel Perspectives on Real-World Challenges in AL Amyloidosis: What Would You Do?1.25JA0007105-0000-26-053-H01-PMedscapeFree01/30/2027https://www.medscape.org/viewarticle/panel-perspectives-real-world-challenges-al-amyloidosis-what-2026a10002mlView Free CE
SERD Strategy Lab: A Blueprint for Pharmacist-Led Implementation of Oral SERDs in HR+/HER2– Metastatic Breast Cancer1.000290-0000-26-276-L01-PPharmacy TimesFree02/02/2027https://www.pharmacytimes.org/courses/serd-strategy-lab-a-blueprint-for-pharmacist-led-implementation-of-oral-serds-in-hrher2-metastatic-breast-cancerView Free CE
Line by Line: Strategic Decision-Making in Advanced Colorectal Cancers1.25JA0007105-0000-26-020-H01-PMedscapeFree02/05/2027https://www.medscape.org/viewarticle/line-line-strategic-decision-making-advanced-colorectal-2026a10003a3View Free CE
The Solution to IV Fluid Management: Best Practices for Fluid Stewardship1.500204-0000-24-412-H01-PASHPFree02/13/2027https://elearning.ashp.org/products/12445/the-solution-to-iv-fluid-management-best-practices-for-fluid-stewardshipView Free CE
Checkpoint Well Taken: Identification and Management of Immune Related Adverse Events for Healthcare Practitioners1.500204-0000-25-410-H01-PASHPFree02/19/2027https://elearning.ashp.org/products/13610/checkpoint-well-taken-identification-and-management-of-immune-related-adverse-events-for-healthcare-practitionersView Free CE
Navigating the Complex Landscape of Pulmonary Arterial Hypertension: A Roadmap for Pharmacists1.500204-0000-25-409-H01-PASHPFree02/19/2027https://elearning.ashp.org/products/13570/navigating-the-complex-landscape-of-pulmonary-arterial-hypertension-a-roadmap-for-pharmacistsView Free CE
The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks1.500204-0000-25-415-H01-PASHPFree02/19/2027https://elearning.ashp.org/products/13615/the-whole-kidney-and-caboodle-incorporating-guideline-based-recommendations-to-identify-and-manage-chronic-kidney-disease-and-reduce-cardiovascular-risksView Free CE
And the Beat Goes On: Improving Heart Failure and Chronic Kidney Disease Outcomes with SGLT2 Inhibitors1.500204-0000-25-408-H01-PASHPFree02/19/2027https://elearning.ashp.org/products/13617/and-the-beat-goes-on-improving-heart-failure-and-chronic-kidney-disease-outcomes-with-sglt2-inhibitorsView Free CE
Between a Rock and a Hard Plaque: The Relationship Between LDL-C and ASCVD Risk and Improving Patient Outcomes with PCSK9 Inhibitors1.500204-0000-25-417-H01-PASHPFree02/19/2027https://elearning.ashp.org/products/13616/between-a-rock-and-a-hard-plaque-the-relationship-between-ldl-c-and-ascvd-risk-and-improving-patient-outcomes-with-pcsk9-inhibitorsView Free CE
Evolving Strategies for Identifying and Treating Uncomplicated Urinary Tract Infections:Filling the Gaps Across Clinical Settings2.000396-0000-25-041-H01-PPowerPakFree02/20/2027https://www.powerpak.com/course/preamble/207860View Free CE
Under Pressure: The Pharmacist’s Role in Pulmonary Arterial Hypertension0.500204-0000-26-404-H01-PASHPFree02/24/2027https://elearning.ashp.org/products/13647/under-pressure-the-pharmacists-role-in-pulmonary-arterial-hypertensionView Free CE
RAS-Targeted Strategies in Pancreatic Cancer: Progress and Future Directions1.25JA0007105-0000-26-015-H01-PMedscapeFree02/25/2027https://www.medscape.org/viewarticle/ras-targeted-strategies-pancreatic-cancer-progress-and-2026a100033cView Free CE
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Changing Therapeutic Landscape and the Role of the Pharmacist1.500204-0000-25-414-H01-PASHPFree02/26/2027https://elearning.ashp.org/products/13648/chronic-inflammatory-demyelinating-polyneuropathy-cidp-a-changing-therapeutic-landscape-and-the-role-of-the-pharmacistView Free CE
Inside CIDP Treatment: What Pharmacists Need to Know0.500204-0000-26-400-H01-PASHPFree02/26/2027https://elearning.ashp.org/products/13701/inside-cidp-treatment-what-pharmacists-need-to-knowView Free CE
18th Annual Hematologic Malignancies Demystified, Session I2.50JA0007105-0000-26-104-H01-PMedscapeFree02/26/2027https://www.medscape.org/viewarticle/eighteenth-annual-hematologic-malignancies-demystified-2026a10005gwView Free CE
Bridging the Gap in Hyperkalemia Care: An Interdisciplinary Panel on Treatment and GDMT Optimization1.500430-9999-26-039-H01-PPowerPakFree03/13/2027https://www.powerpak.com/course/preamble/207977View Free CE
Addressing the Impact of CKD on Cardiovascular-Kidney-Metabolic Syndrome Through Team-Based Care1.25JA0004461-0000-26-005-H01-PMedscapeFree03/31/2027https://www.medscape.org/viewarticle/1003272View Free CE
Optimizing Secondary Stroke Prevention:Addressing Unmet Needs in Non-Cardioembolic Ischemic Stroke1.50JA4008073-9999-26-290-H01-PPowerPakFree03/31/2027https://www.powerpak.com/course/preamble/209175View Free CE
Strategies for Improving ERBB2 (HER2) Testing in NSCLC Within Community Settings2.500396-0000-26-003-H01-PPowerPakFree04/01/2027https://www.powerpak.com/course/preamble/208017View Free CE
The Evolving Management of Non-Cystic Fibrosis Bronchiectasis: Preparing for the Arrival of Novel Therapeutic Approaches (Archive)1.250430-9999-26-015-H01-PPowerPakFree04/08/2027https://www.powerpak.com/course/preamble/207916View Free CE
Optimizing Stroke Prevention and Anticoagulation in Atrial Fibrillation1.500290-9999-26-049-H01-PPharmacy TimesFree04/10/2027https://www.pharmacytimes.org/courses/optimizing-stroke-prevention-and-anticoagulation-in-atrial-fibrillation-ogutView Free CE
The Evolving Management of Non-Cystic Fibrosis Bronchiectasis: Preparing for the Arrival of Novel Therapeutic Approaches (Archive)1.250430-9999-26-015-H01-PMedscapeFree04/22/2027https://www.medscape.org/viewarticle/evolving-management-non-cystic-fibrosis-bronchiectasis-2026a1000b1tView Free CE
A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension1.500290-0000-26-081-H01-PPharmacy TimesFree04/30/2027https://www.pharmacytimes.org/courses/a-managed-care-perspective-on-hard-to-control-hypertension-understanding-the-risks-and-challenges-in-uncontrolled-and-resistant-hypertension-pkt4View Free CE
Redefining Value in Transthyretin Amyloidosis Cardiomyopathy Care: Innovations in Diagnosis, Treatment, and Access1.500290-0000-26-094-H01-PPharmacy TimesFree04/30/2027https://www.pharmacytimes.org/courses/redefining-value-in-transthyretin-amyloidosis-cardiomyopathy-care-innovations-in-diagnosis-treatment-and-accessView Free CE
Next-Generation Lipid Management: Elevating Outcomes Through Managed Care Strategies1.500290-0000-26-098-H01-PPharmacy TimesFree04/30/2027https://www.pharmacytimes.org/courses/next-generation-lipid-management-elevating-outcomes-through-managed-care-strategies-4zryView Free CE
Collaborative Approaches to Implementing Durable Anti-VEGF Solutions in an Evolving Retinal Landscape0.50JA4008332-0000-26-033-H01-PFreeCMEFree05/04/2027https://www.freecme.com/products/collaborative-approaches-to-implementing-durable-anti-vegf-solutions-in-an-evolving-retinal-landscapeView Free CE
Applying Value-Based Principles in ATTR-CM Care: Optimizing Identification, Therapy Selection, and Patient Access1.500290-0000-26-107-H01-PPharmacy TimesFree05/11/2027https://www.pharmacytimes.org/courses/applying-value-based-principles-in-attr-cm-care-optimizing-identification-therapy-selection-and-patient-access-cen4View Free CE
Personalizing Breast Cancer Care: Pharmacist Strategies for Optimizing Oral Therapy Outcomes1.50290-0000-26-125-H01-PPharmacy TimesFree05/12/2027https://www.pharmacytimes.org/courses/personalizing-breast-cancer-care-pharmacist-strategies-for-optimizing-oral-therapy-outcomes-unnpView Free CE
Acute And Chronic Hyperkalemia: Treatment Options, Potassium Binders, And Clinical Cases2.000009-0000-24-026-H01-PUConn School of PharmacyFree05/15/2027https://pharmacy.uconn.edu/course/hyperkalemia/View Free CE
CGM in Action: Mini Cases for Mastering Best Practices in People with Type 2 Diabetes0.50JA4008191-9999-26-029-H01-PFreeCMEFree05/27/2027https://www.freecme.com/products/cgm-in-action-mini-cases-for-mastering-best-practices-in-people-with-type-2-diabetesView Free CE
Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments1.25JA0007144-0000-26-235-H01-PPrimeFree05/28/2027https://primeinc.org/online/updates-refractory-chronic-cough-diagnosis-disease-burden-underlyingView Free CE
Prostatic Artery Embolization (PAE) University: Strategies for Treating BPH and LUTS2.50JA4008162-9999-26-489-H01-PmyCMEFree06/15/2027https://www.mycme.com/courses/prostatic-artery-embolization-university-treating-bph-luts-10812View Free CE
Breaking the Clot: Factor XIa Inhibition and the Future of Stroke Prevention1.000290-0000-26-177-H01-PPharmacy TimesFree06/17/2027https://www.pharmacytimes.org/courses/breaking-the-clot-factor-xia-inhibition-and-the-future-of-stroke-prevention-hgr6View Free CE
Beyond Statins: Evidence-Based Approaches to Achieving LDL-C Targets and Reducing Atherosclerotic Cardiovascular Disease Risk1.500290-0000-26-182-H01-PPharmacy TimesFree06/25/2027https://www.pharmacytimes.org/courses/beyond-statins-evidence-based-approaches-to-achieving-ldl-c-targets-and-reducing-atherosclerotic-cardiovascular-disease-risk-x6jcView Free CE
Eye on Relief: Pharmacist-Driven Care in Allergic Conjunctivitis (Pharmacist Credit)2.000290-0000-26-183-H01-PPharmacy TimesFree06/26/2027https://www.pharmacytimes.org/courses/eye-on-relief-pharmacist-driven-care-in-allergic-conjunctivitis-pharmacist-creditView Free CE
Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances1.000290-9999-26-201-H01-PPharmacy TimesFree06/30/2027https://www.pharmacytimes.org/courses/improving-outcomes-in-lipid-management-aligning-managed-care-policy-with-emerging-guideline-updates-and-non-statin-therapeutic-advances-lwivView Free CE
Advancing Anticoagulation Strategies in Atrial Fibrillation: Evidence, Guidelines, and Patient-Centered Care1.000290-0000-26-205-H01-PPharmacy TimesFree06/30/2027https://www.pharmacytimes.org/courses/advancing-anticoagulation-strategies-in-atrial-fibrillation-evidence-guidelines-and-patient-centered-careView Free CE
CETP Inhibition: Exploring the Cardiovascular and Neurocognitive Implications1.25JA0006104-9999-26-007-H01-PFreeCMEFree07/09/2027https://www.freecme.com/products/cetp-inhibition-exploring-the-cardiovascular-and-neurocognitive-implicationsView Free CE
CETP Inhibition: Exploring the Cardiovascular and Neurocognitive Implications1.25JA0006104-9999-26-008-H01-PmyCMEFree07/09/2027https://www.mycme.com/courses/cetp-inhibition-cardiovascular-neurocognitive-implications-10844View Free CE
Managing Itchy Eyes: A Pharmacist’s Approach to Seasonal and Perennial Allergic Conjunctivitis2.000430-0000-26-074-H01-PPowerPakFree07/15/2027https://www.powerpak.com/course/preamble/208860View Free CE
nsMRAs in CKM Syndrome: Disease-Specific Deep Dives1.25JA0007105-0000-26-351-H01-PMedscapeFree07/17/2027https://www.medscape.org/viewarticle/nsmras-ckm-syndrome-disease-specific-deep-dives-2026a1000ntxView Free CE
Aging with HIV and CKD: Evidence-Based Management Across the Care Continuum1.25JA0000185-0000-26-048-H01-PPowerPakFree07/19/2027https://www.powerpak.com/course/preamble/208943View Free CE
Optimize Hybrid Closed Loop Insulin Pumps: A How-To Guide1.25JA4008258-0000-25-266-H01-PAssociation of Diabetes Care & Educational SpecialistsFree07/23/2027https://www.adces.org/store/online-education/detail/optimize-hybrid-closed-loop-insulin-pumps-a-how-to-guide-recordedView Free CE
Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages1.000290-0000-26-237-H01-PPharmacy TimesFree07/23/2027https://www.pharmacytimes.org/courses/stimulant-stewardship-a-pharmacists-guide-to-adhd-prescribing-during-drug-shortages-9xwqView Free CE
Getting to the Sweet Spot: The Emerging Use of Once-Weekly Basal Insulin Therapies in Type 2 Diabetes1.000204-0000-26-410-H01-PASHPFree07/28/2027https://elearning.ashp.org/products/14173/getting-to-the-sweet-spot-the-emerging-use-of-once-weekly-basal-insulin-therapies-in-type-2-diabetesView Free CE
Hypercortisolism: From Diagnosis to Long-Term Control1.50JA0007105-0000-26-324-H01-PMedscapeFree07/31/2027https://www.medscape.org/viewarticle/hypercortisolism-diagnosis-long-term-control-2026a1000pudView Free CE
Lipid Management in an Era of Evolving Evidence1.75JA0006104-9999-26-011-H01-PFreeCMEFree08/05/2027https://www.freecme.com/products/lipid-management-in-an-era-of-evolving-evidenceView Free CE
Lipid Management in an Era of Evolving Evidence1.75JA0006104-9999-26-012-H01-PmyCMEFree08/05/2027https://www.mycme.com/courses/lipid-management-in-an-era-of-evolving-evidence-10882View Free CE
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer (mPC) Landscape2.25JA4008162-9999-26-561-H01-PFreeCMEFree08/07/2027https://www.freecme.com/products/parp-inhibitor-combination-treatments-biomarker-testing-safety-and-efficacy-in-a-rapidly-changing-metastatic-prostate-cancer-mpc-landscapeView Free CE
Partnering for Progress: NMIBC Risk Assessment, Surveillance, and Intravesical Therapy2.00JA4008162-9999-26-569-H01-PmyCMEFree08/19/2027https://www.mycme.com/courses/nmibc-risk-assessment-surveillance-and-intravesical-therapy-10900View Free CE
Expanding the Therapeutic Landscape for Systemic Lupus Erythematosus and Lupus Nephritis: Moving into an Era of Targeted Therapy and Collaborative Care (Archive)1.250430-9999-26-072-H01-PPowerPakFree08/20/2027https://www.powerpak.com/course/preamble/208979View Free CE
Empowering Pharmacists in Obesity Care: From Clinical Skills to Counseling0.75JA4008162-9999-26-560-H01-PPowerPakFree08/30/2027https://www.powerpak.com/course/preamble/209104View Free CE
Expanding PrEP Access in Rural and Underserved Communities: A Practical Approach to HIV Prevention1.50JA4008332-0000-26-054-H01-PFreeCMEFree09/03/2027https://www.freecme.com/products/expanding-prep-access-in-rural-and-underserved-communities-a-practical-approach-to-hiv-preventionView Free CE
CIDP Masterclass: Early Diagnosis, Emerging Options, Better Outcomes1.25JA0000185-0000-26-060-H01-PmyCMEFree09/03/2027https://www.mycme.com/courses/cidp-masterclass-early-diagnosis-emerging-options-better-outcomes-10934View Free CE
Partnering for Progress: Co-managed Clinics and Patient-Centered Treatment Sequencing in NMIBC2.00JA4008162-9999-26-562-H01-PmyCMEFree09/06/2027https://www.mycme.com/courses/patient-centered-treatment-sequencing-in-non-muscle-invasive-bladder-cancer-10883View Free CE
Fresh from ADCES26: Game Plan for Basal Insulin: Winning Strategies from Initiation to Adjustment1.25JA4008258-9999-26-300-H01-PAssociation of Diabetes Care & Educational SpecialistsFree09/07/2027https://www.adces.org/store/online-education/detail/game-plan-for-basal-insulin-winning-strategies-from-initiation-to-adjustmentView Free CE
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer (mPC) Landscape2.25JA4008162-9999-26-561-H01-PmyCMEFree09/07/2027https://www.mycme.com/courses/parp-inhibitor-combination-treatments-metastatic-prostate-cancer-10896View Free CE
Expanding the Therapeutic Landscape for Systemic Lupus Erythematosus and Lupus Nephritis: Moving into an Era of Targeted Therapy and Collaborative Care(Archive)1.250430-9999-26-072-H01-PPowerPakFree09/20/2027https://www.powerpak.com/course/preamble/208979View Free CE
Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches1.00JA0007144-0000-26-358-H01-PPrimeFree09/25/2027https://primeinc.org/online/navigating-advances-obesity-management-amylin-biology-emerging-therapeuticView Free CE
Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection1.00JA0007144-0000-26-387-H01-PPrimeFree09/30/2027https://primeinc.org/online/enhancing-comprehensive-biomarker-testing-biomarker-directed-treatment-selectionView Free CE
Mycophenolate Therapy and Associated Fetal Risk: Improving Healthcare Providers’ Competence in Pregnancy Planning and Contraception Counseling (Recorded Panel Discussion)1.000430-9999-25-116-H01-PPowerPakFree10/31/2027https://www.powerpak.com/course/preamble/138357View Free CE
Familial Chylomicronemia Syndrome 1011.00JA0007144-9999-25-384-H01-PPrimeFree11/04/2027https://primeinc.org/podcast/familial-chylomicronemia-syndrome-101View Free CE
Rx for Change: Clinician-Assisted Tobacco Cessation7.000018-0000-25-045-H01-PPurdue UniversityFree11/07/2027https://www.eventreg.purdue.edu/ec2k/courselisting.aspx?master_id=6293&master_version=1&course_area=1335&course_number=788&course_subtitle=00View Free CESmoking Cessation
Recorded Bugs & Drugs: An Antimicrobial Agents Review2.000001-9999-24-050-H01-PAuburn University Harrison School of PhramacyFree11/13/2027https://aub.ethosce.com/content/recorded-bugs-drugs-antimicrobial-agents-review#group-tabs-node-course-default5View Free CE
Let’s Stop Moving: Management of Acute Diarrhea in the Ambulatory Setting2.000009-0000-24-053-H01-PUConn School of PharmacyFree11/15/2027https://pharmacy.uconn.edu/course/lets-stop-moving-management-of-acute-diarrhea-in-the-ambulatory-setting/View Free CE
Tobacco Cessation: Behavioral Counseling & Pharmacotherapy2.500018-0000-25-046-H01-PPurdue UniversityFree12/22/2027https://www.eventreg.purdue.edu/ec2k/courselisting.aspx?1=%20&master_ID=6318%20&course_area=1598%20&course_number=356%20&course_subtitle=00View Free CESmoking Cessation
Tobacco Cessation: Pharmacists' Prescribing for Tobacco Cessation2.000018-0000-25-047-H01-PPurdue UniversityFree12/22/2027https://www.eventreg.purdue.edu/ec2k/courselisting.aspx?master_id=6318&master_version=1&course_area=1598&course_number=355&course_subtitle=00View Free CESmoking Cessation
Pancreatic Cancer 101: From Diagnosis, Detection to Patient Experience1.00JA0007144-9999-26-084-H01-PPrimeFree03/12/2028https://primeinc.org/podcast/pancreatic-cancer-101-diagnosis-detection-patient-experienceView Free CE
From Genes to Nutrition: Supporting FCS Patients with Experts1.00JA0007144-9999-26-152-H01-PPrimeFree03/19/2028https://primeinc.org/podcast/genes-nutrition-supporting-fcs-patients-expertsView Free CE
Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors1.00JA0007144-0000-26-141-H01-PPrimeFree03/30/2028https://primeinc.org/online/bridging-specialties-manage-hyperglycemia-breast-cancer-patients-treated-pi3kView Free CE
SMARTen Up: Asthma Management Guidelines2.000009-0000-25-031-H01-PUConn School of PharmacyFree04/19/2028https://pharmacy.uconn.edu/course/smartenupasthma/View Free CE
Sjogren’s Disease: How Dry Am I?2.000009-0000-25-050-H01-PUConn School of PharmacyFree09/01/2028https://pharmacy.uconn.edu/course/sjogrens-2025how-dry-am-i-2/View Free CE
Escape from Tick Island1.000669-0000-25-098-H01-PRxCeFree09/27/2028https://rxce.com/Escape-from-Tick-Island-Pharmacist/PharmacyView Free CE
Pet Allergies2.000009-0000-26-020-H01-PUConn School of PharmacyFree03/25/2029http://pharmacy.uconn.edu/course/petallergies/View Free CE
Maximizing Outcomes: The Impact of Oral Medications on Weight Management2.00JA4008424-0000-26-040-H01-PRxCeFree03/30/2029https://rxce.com/maximizing-outcomes-the-impact-of-oral-medications-on-weight-management/PharmacyView Free CE
Targeted Treatment: The Role of Injectables in Weight Loss Management2.00JA4008424-0000-26-041-H01-PRxCeFree03/30/2029https://rxce.com/targeted-treatment-the-role-of-injectables-in-weight-loss-management/PharmacyView Free CE
Pharmacologic Approaches to Diabetes Management: Glucagon-Like Peptide-1 Based Therapies2.00A4008424-0000-26-045-H01-PRxCeFree04/03/2029https://rxce.com/pharmacologic-approaches-to-diabetes-management-glucagon-like-peptide-based-therapies/PharmacyView Free CE
Updates in Hypertension Guidelines: Translating Evidence into Practice2.000009-0000-26-031-H01-PUConn School of PharmacyFree06/15/2029https://pharmacy.uconn.edu/course/hypertensionupdates/View Free CE
The Gall of it All: Gallbladder Disease2.000009-0000-26-034-H01-PUConn School of PharmacyFree06/16/2029https://pharmacy.uconn.edu/course/gallbladderdisease-2026-2/View Free CE
Pharmacist Medication Therapy Management (MTM)1.00JA4008424-0000-26-166-H01-PRxCeFree07/14/2029https://rxce.com/medication-therapy-management-conducting-a-patient-centered-medication-review/PharmacyView Free CE
Linking Experts and Primary Care Clinicians to Improve Recognition​ and Management of IBD in Rural and Underserved Communities – Lessons Learned​1.00JA4008332-0000-26-007-H01-PFreeCMEFree09/31/2027https://www.freecme.com/products/linking-experts-and-primary-care-clinicians-to-improve-recognition-and-management-of-ibd-in-rural-and-underserved-communities-lessons-learnedView Free CE
Optimizing Nondrowsy Allergy Relief for Allergic Rhinitis: The Pharmacist’s Role in Evidence-Based OTC Decision-Making2.000290-0000-26-253-H01-PPharmacy TimesFree09/31/2027https://www.pharmacytimes.org/courses/optimizing-non-drowsy-allergy-relief-for-allergic-rhinitis-the-pharmacists-role-in-evidence-based-otc-decision-makingView Free CE
Narcolepsy Is More Common Than You Think: Identifying Patients With Type 1 Narcolepsy in Primary Care1.50JA0007105-0000-25-360-H01-PMedscapeFree10/272026https://www.medscape.org/viewarticle/narcolepsy-more-common-than-you-think-identifying-patients-2025a1000ss3View Free CE
Scroll to Top